Vinati Organics Q2 FY27: PAT falls 32% YoY as margins compress despite 24% revenue growth
PAT -31.8% YoY · revenue +23.62% · margins compressing · miss vs street
₹680.21 Cr
+23.62% YoY
₹78.36 Cr
-31.8% YoY
11.31%
-9pp YoY
₹7.56
Vinati Organics' consolidated revenue rose 23.6% YoY to Rs680.21 Cr (Rs550.22 Cr a year ago) but was down 2.3% QoQ from Rs695.91 Cr in Q1 FY27. Consolidated PAT fell 31.8% YoY to Rs78.36 Cr (Rs114.88 Cr) and 28.0% QoQ (Rs108.86 Cr) — a clean operating decline with no exceptional items on either side of the comparison, so the raw and adjusted YoY PAT change are the same at -31.8%. Standalone told a similar story: PAT of Rs86.84 Cr (EPS Rs8.38) against consolidated PAT of Rs78.36 Cr (EPS Rs7.56), a roughly Rs8.5 Cr subsidiary-level drag this quarter.
Q2 FY-2027 vs prior quarters
The entire story sits on the cost line, not revenue. Operating margin (EBITDA/revenue) compressed to 18.48% from 30.41% a year ago and 24.50% last quarter — a contraction of about 1,193 bps YoY and 602 bps QoQ — while net margin fell to roughly 11.5% of revenue from ~20.9% a year ago. Cost of materials consumed jumped to Rs404.22 Cr, or 59.4% of revenue, versus Rs263.68 Cr (47.9% of revenue) in the year-ago quarter, even as revenue grew strongly; input-cost pressure clearly outran both pricing and the revenue gain this quarter.
The stock went into the print at ₹968.4, down 17.5% over the past month of trading.
Management is targeting approximately 15% volume growth at the company level in FY 2027, with specific product segments like ATBS, IB, HP-MTBE, and customized products expected to contribute significantly. The company plans to invest INR 200-250 crores in capex for FY 2027, focusing on capacity expansion, innovation, a
— This quarter: missed
The print missed Street: Prabhudas Lilladher's preview had modelled Q2 FY27 net sales of Rs609.8 Cr, EBITDA of Rs186.2 Cr and PAT of Rs127.6 Cr (+20.3% YoY). Actual revenue came in well above that (Rs680.2 Cr), but EBITDA (~Rs125.7 Cr) and PAT (Rs78.4 Cr) landed far short — the beat was entirely on the top line, and profitability missed by roughly a third. Against management's own guidance from the Q4 FY26 concall — ~15% FY27 volume growth and EBITDA margins held in the 26-27% range — the quarter's 23.6% YoY revenue growth clears the volume bar, but the 18.48% operating margin is nowhere close to the guided range, a clear miss on profitability guidance. The quarter's other disclosed corporate actions (a Rs9 Cr investment in a wholly owned subsidiary on Sep 21, trading-window closure ahead of results, BRSR/AGM filings in August) are governance and administrative in nature and do not explain the margin move; no management press release accompanied this filing to give a direct driver explanation.
W1
Whether OPM recovers toward management's guided 26-27% EBITDA margin band in H2 FY27, from 18.5% this quarter
W2
Raw-material cost trajectory for ATBS/IB/HP-MTBE inputs — cost of materials consumed was 59.4% of revenue this quarter vs 47.9% a year ago
W3
New product revenue contribution guided to start from Q3 FY27, alongside the Rs200-250 Cr FY27 capex plan
No exceptional items in current or comparative periods (row shows '-' throughout). Consolidated review flags one foreign subsidiary (H1 revenue Rs21.52 Cr, H1 PAT Rs1.11 Cr) and one trust entity as unreviewed but immaterial to the group. No management press release text was available for this filing, so management framing is limited to the board-outcome letter and auditor notes.
Informational and educational content only. Not investment advice.